Marius L Calin, MD1, Aziz Sadiq, DO1, Gabriel Arevalo, MD1, Baongoc Nasri, MD2, Rocio C Fuentes, MD1, Kathryn Harris, MD1, Kirpal Singh, MD1. 1Saint Vincent Hospital, 2Bronxlebanon Hospital
Introduction: Aggressive surgical treatment of the patient with liver metastasis secondary to a pancreatic neuroendocrine tumor is accepted and may offer some advantages if the disease is under control and if the patient is a good surgical candidate. The options are open, laparoscopic or robotic.
Materials and Methods: A patient with a pancreatic neuroendocrine tumor, with single liver metastasis, underwent totally robotic multi-visceral resection including the left liver, distal pancreas and spleen with possible curative intention as the disease was not progressing after somatostatin and left hepatic artery embolization.
Results: No complications occurred and the procedure was performed entirely robotic. The estimated blood loss was 100 mL. The patient had a short hospital stay.
Discussions: We present here the video of the first reported case of a robotic left hepatectomy, distal pancreatectomy, and splenectomy for a metastatic pancreatic neuroendocrine tumor. The technical details of the main steps are explained. Overall, the excellent visualization of the anatomy, the easy dissection, a good hemostatic control with minimal blood loss, a short hospital stay wit quick recovery and the excellent cosmetic results made us consider it as a successful short-term outcome.
Conclusion: The robotic approach was feasible and could possibly overcome some limitations of the laparoscopic approach.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 78293
Program Number: V020
Presentation Session: HPB
Presentation Type: Video